Detalhe da pesquisa
1.
In ER-Positive, HER2-Negative Breast Cancers, HER2 mRNA Levels Correlate Better with Clinicopathologic Features and Oncotype DX Recurrence Score than HER2 Immunohistochemistry.
Lab Invest
; 104(3): 100309, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135156
2.
Umbilical Appendix Masquerading as a Patent Omphalomesenteric Duct in a Neonate.
Pediatr Dev Pathol
; 25(4): 474-478, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344403
3.
HER2-low breast cancers: Current insights and future directions.
Semin Diagn Pathol
; 39(5): 305-312, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35872032
4.
Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer.
Ann Surg
; 274(2): e150-e159, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31436549
5.
Dedifferentiated gastrointestinal stromal tumor: Recent advances.
Ann Diagn Pathol
; 39: 118-124, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30661742
6.
Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer.
Am J Pathol
; 186(7): 1900-1912, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27182644
7.
A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer.
Invest New Drugs
; 33(4): 890-4, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25947565
8.
Corrigendum to "Immunohistochemistry in the workup of bladder biopsies. Frequency, variation and utility of use at an academic center" [Ann. Diagn. Pathol. 41(2019) 124-128].
Ann Diagn Pathol
; 46: 151513, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32330661
9.
Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.
Breast Cancer Res
; 16(6): 3417, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25551582
10.
Validation and interpretation of Pan-TRK immunohistochemistry: a practical approach and challenges with interpretation.
Diagn Pathol
; 19(1): 10, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38200576
11.
Neutrophil Elastase Remodels Mammary Tumors to Facilitate Lung Metastasis.
Mol Cancer Ther
; 23(4): 492-506, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37796181
12.
Diffuse pulmonary meningotheliomatosis with pan-TRK expression by immunohistochemistry: a novel finding and potential pitfall.
Diagn Pathol
; 18(1): 22, 2023 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36782261
13.
Histopathologic Aspects of Malignancy-Associated Granuloma Annulare: A Single Institution Experience.
Dermatopathology (Basel)
; 10(1): 95-103, 2023 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36975384
14.
Interobserver and Interantibody Reproducibility of HER2 Immunohistochemical Scoring in an Enriched HER2-Low-Expressing Breast Cancer Cohort.
Am J Clin Pathol
; 159(5): 484-491, 2023 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36856777
15.
HER2 categorical changes after neoadjuvant chemotherapy: A study of 192 matched breast cancers with the inclusion of HER2-Low category.
Hum Pathol
; 142: 34-41, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37979952
16.
Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time.
Cancer Res
; 83(6): 939-955, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603130
17.
Subepidermal Calcified Nodule in a Child With Neurofibromatosis Type 1.
Cureus
; 14(3): e23261, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35449679
18.
Paget's disease of the breast.
J Carcinog
; 10: 31, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22279416
19.
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers.
Oncogenesis
; 10(5): 40, 2021 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33990543
20.
Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration.
Cancers (Basel)
; 13(7)2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33916118